Blis Technologies Ltd operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Blis Technologies Ltd with three other
pharmaceutical manufacturers in Australasia:
sales of 11.97 billion Australian Dollars [US$8.07 billion]
of which 84%
was CSL Behring),
(609.50 million Australian Dollars [US$411.27 million]
AFT Pharmaceuticals Ltd
(85.13 million New Zealand Dollars [US$54.78 million]
of which 59%
During the year ended March of 2019, sales at
Blis Technologies Ltd were 8.41 million New Zealand Dollars (US$5.41 million).
increase of 59.0%
versus 2018, when the company's sales were 5.29 million New Zealand Dollars.